# Margaret von Mehren

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/margaret-von-mehren/

## Facts

| Field | Value |
| --- | --- |
| Citations | 34,569 |
| Field | Gastrointestinal Tumor Research and Treatment |
| h-index | 76 |
| i10-index | 219 |
| Last Known Institution | Fox Chase Cancer Center |
| OpenAlex ID | https://openalex.org/A5085336500 |
| ORCID iD | https://orcid.org/0000-0001-6158-890X |
| Works | 478 |

## Researcher papers

- [NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors](https://scholariq.org/papers/nccn-task-force-report-update-on-the-management-of-patients-with/)
- [Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/soft-tissue-sarcoma-version-2-2022-nccn-clinical-practice-guidelines-in-oncology/)
- [Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial](https://scholariq.org/papers/efficacy-and-safety-of-trabectedin-or-dacarbazine-for-metastatic-liposarcoma-or/)
- [Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/soft-tissue-sarcoma-version-2-2018-nccn-clinical-practice-guidelines-in-oncology/)
- [Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules](https://scholariq.org/papers/efficacy-and-safety-of-trabectedin-in-patients-with-advanced-or-metastatic/)
- [NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021](https://scholariq.org/papers/nccn-guidelines-insights-soft-tissue-sarcoma-version-1-2021/)
- [NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022](https://scholariq.org/papers/nccn-guidelines-insights-gastrointestinal-stromal-tumors-version-2-2022/)

## Researcher topics

- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Gastrointestinal disorders and treatments](https://scholariq.org/topics/gastrointestinal-disorders-and-treatments/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [Fox Chase Cancer Center](https://scholariq.org/institutions/fox-chase-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.